V.A.C. VERAFLO
Device
KCI USA, Inc.
Total Payments
$596,554
Transactions
2,074
Doctors
1,460
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $134,494 | 458 | 326 |
| 2023 | $195,132 | 504 | 391 |
| 2022 | $94,317 | 544 | 438 |
| 2021 | $172,611 | 568 | 432 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $168,059 | 7 | 28.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $140,340 | 56 | 23.5% |
| Consulting Fee | $115,571 | 75 | 19.4% |
| Food and Beverage | $77,356 | 1,679 | 13.0% |
| Travel and Lodging | $68,247 | 191 | 11.4% |
| Education | $14,918 | 40 | 2.5% |
| Grant | $11,998 | 25 | 2.0% |
| Debt forgiveness | $63.89 | 1 | 0.0% |
Payments by Type
General
$428,495
2,067 transactions
Research
$168,059
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of Vacuum-Assisted Closure Veraflo Therapy with Cleanse Choice Dressing on Wound Healing in Patients with Pressure Sores: A Prospective, Randomized Controlled Trial | KCI USA, Inc. | $102,038 | 0 |
| A post-market, prospective, multi-center, single-arm study evaluating the safety and efficacy of the 3M V.A.C. Peel and Place Dressing used in conjunction with 3M V.A.C.Therapy | Solventum Corporation | $22,330 | 0 |
| Use of V.A.C. VERAFLO to Deliver Pro-Healing and Anti-Infective Agents in an Acute Porcine Model of Surgical Wounds | KCI USA, Inc. | $20,000 | 0 |
| A Retrospective Post Market Clinical F/u (PMCF) Survey of V.A.C. VERAFLTM Therapy in Burns | KCI USA, Inc. | $8,950 | 0 |
| Impact of VAC Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice | KCI USA, Inc. | $7,209 | 0 |
| Quintero-Perez - ISR Approved Study entitled Negative Pressure Wound Therapy as a Salvage Procedure | KCI USA, Inc. | $5,000 | 0 |
| Conway - Approved ISR Study Publication Fee | KCI USA, Inc. | $2,532 | 0 |
Top Doctors Receiving Payments for V.A.C. VERAFLO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Phoenix, AZ | $180,340 | 37 |
| , DPM | Foot & Ankle Surgery | Boston, MA | $70,514 | 39 |
| , D.D.S | Orthodontics and Dentofacial Orthopedics | Stillwater, MN | $42,710 | 2 |
| , MD | Surgical Critical Care | Phoenix, AZ | $27,973 | 19 |
| , CRNP | Adult Health | Boyertown, PA | $19,829 | 26 |
| , DPM | Podiatrist | Westerville, OH | $17,078 | 30 |
| , DPM | Podiatrist | Greenville, SC | $16,332 | 16 |
| , APRN, AGNP-C | Nurse Practitioner | West Fargo, ND | $14,384 | 17 |
| , M.D | Plastic Surgery | Glendale, AZ | $11,019 | 28 |
| , M.D | Plastic Surgery | Newport Beach, CA | $9,853 | 12 |
| , MD | Orthopaedic Surgery | San Antonio, TX | $9,774 | 11 |
| , MD | Plastic Surgery | Annapolis, MD | $9,017 | 10 |
| , M.D | Plastic Surgery | Miami, FL | $7,245 | 15 |
| , CRNP | Primary Care | Mohrsville, PA | $6,618 | 20 |
| , MD | Surgical Critical Care | Saint Louis, MO | $5,250 | 3 |
| , MD | Orthopaedic Surgery | Stanford, CA | $4,550 | 3 |
| , MD | Trauma Surgery | Tyler, TX | $3,907 | 9 |
| , M.D | Orthopaedic Surgery | New York, NY | $3,500 | 1 |
| , MD | Orthopaedic Surgery | San Antonio, TX | $3,175 | 12 |
| , D.O | Plastic Surgery | Boca Raton, FL | $3,134 | 15 |
| , M.D., M.B.A | Plastic Surgery | Lebanon, NH | $2,797 | 4 |
| , M.D | Plastic Surgery | San Antonio, TX | $2,625 | 1 |
| , M.D | Orthopaedic Surgery | New York, NY | $2,398 | 10 |
| , M.D | Orthopaedic Trauma | Seattle, WA | $2,363 | 5 |
| , MD | Orthopaedic Surgery | New York, NY | $2,315 | 8 |
Ad
Manufacturing Companies
- KCI USA, Inc. $419,350
- Solventum Corporation $134,494
- 3M Company $42,710
Product Information
- Type Device
- Total Payments $596,554
- Total Doctors 1,460
- Transactions 2,074
About V.A.C. VERAFLO
V.A.C. VERAFLO is a device associated with $596,554 in payments to 1,460 healthcare providers, recorded across 2,074 transactions in the CMS Open Payments database. The primary manufacturer is KCI USA, Inc..
Payment data is available from 2021 to 2024. In 2024, $134,494 was paid across 458 transactions to 326 doctors.
The most common payment nature for V.A.C. VERAFLO is "Unspecified" ($168,059, 28.2% of total).
V.A.C. VERAFLO is associated with 7 research studies, including "Evaluation of Vacuum-Assisted Closure Veraflo Therapy with Cleanse Choice Dressing on Wound Healing in Patients with Pressure Sores: A Prospective, Randomized Controlled Trial" ($102,038).